Drug companies will have to refund Medicare for drug waste; how pharma and biotech can keep innovating in a bear market

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: Drug companies will have to start refunding Medicare for certain drugs that get thrown out By Bob Herman Adobe Starting in 2023, Medicare will be refunded for the unused portions of injectable and infused drugs administered by physicians in outpatient clinics. Read More Opinion: STAT+: How pharma and biotech can keep innovating in a bear market By Shane Kovacs Adobe Biotech and pharma companies can make the best of a bear market to sharpen their focus and emerge from it with a stronger trajectory. Read More Opinion: Real-world evidence must not become evidence for abortion-related prosecution By Eric D. Perakslis adobe The Supreme Court's decision on abortion should change how health systems think about sharing and monetizing real-world evidence. Read More Sponsor content by Dermavant First novel topical for plaque psoriasis in 25 years steals the spotlight from biologics Dermavant Sciences announced the FDA approval of their novel topical treatment for adults with mild, moderate, and severe plaque psoriasis – the first and only FDA-approved steroid free topical medication in its class. In clinical trials the treatment demonstrated statistically significant results across primary and secondary endpoints versus vehicle, with no label restrictions on duration of use, body surface area, and an approximately four month off-treatment remittive effect (median time to first worsening). Learn more here. Biden signs order on abortion access after Supreme Court ruling By Seung Min Kim, Zeke Miller, and Chris Megerian — Associated Press Evan Vucci/AP The actions President Biden outlined are limited in their ability to safeguard access to abortion nationwide. Read More Friday, July 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser